SCHEMBL10176532

SCHEMBL10176532

Cc1cc(OCC(=O)O)ccc1/N=C1/NC(=O)/C(=C/c2cnc(NC(=O)C3CC3)s2)S1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN7 P35236 7/20 0.44
PTPN12 Q05209 7/20 0.44
PTPN22 Q9Y2R2 7/20 0.44
POLB P06746 6/20 0.44
DUSP3 P51452 6/20 0.44
PTPN5 P54829 1/20 0.44
PTPN11 Q06124 1/20 0.44
MAPT P10636 4/20 0.42
LMNA P02545 1/20 0.42
NPSR1 Q6W5P4 3/20 0.42
RECQL P46063 1/20 0.42
GPR35 Q9HC97 1/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
MAPK1 P28482 1/20 0.39
HPGD P15428 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
PLA2G1B P04054 1/20 0.38
APEX1 P27695 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL699657 0.92 MAPT (0.41) PTPN7PTPN12PTPN22POLBDUSP3
SCHEMBL10176528 0.92 MAPT (0.42) PTPN7PTPN12PTPN22POLBDUSP3
SCHEMBL650770 0.92 MAPT (0.41) PTPN7PTPN12PTPN22POLBDUSP3
SCHEMBL651724 0.91 PTPN7 (0.44) PTPN7PTPN12PTPN22POLBDUSP3
SCHEMBL10176547 0.91 MAPT (0.47) POLBPTPN11MAPTLMNANPSR1
SCHEMBL652415 0.89 MAPT (0.41) PTPN7PTPN12PTPN22POLBDUSP3
SCHEMBL653897 0.88 MAPT (0.40) PTPN7PTPN12PTPN22POLBDUSP3
SCHEMBL653891 0.88 MAPT (0.41) POLBMAPTLMNANPSR1RECQL
SCHEMBL653892 0.88 MAPT (0.41) POLBMAPTLMNANPSR1RECQL
SCHEMBL10176434 0.88 HPGD (0.41) POLBMAPTLMNANPSR1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE CDC7, CDK17, CDCA2 PTPN7 437/4885PTPN12 1722/4885PTPN22 1463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.